Biotech Capabilities

One narrative. All surfaces.

Every substantial Venture Shape engagement begins by structuring the investor narrative, then carries that thinking into the investor-facing surface the company actually needs.

Execution surface

Investor-Facing
Websites

Investor-facing biotech websites that make the company, science, programs and pipeline easier to understand.

  • Ostium Bio makes a half-life problem and the chemistry that fixes it legible without an equation.
  • Nexora Biosystems states the instrument, the workflow and the applications in one pass.
  • Aperiod Therapeutics turns a once-weekly dosing profile into something an investor can feel.
  • Cytovara Therapeutics makes an adaptive CAR-T platform legible to a generalist investor.
  • Halden Bio shows what a steady dose does to the curve, and why the patch is the point.
  • CMS

    Works with the system you use. Venture Shape can build within your existing CMS or recommend the right platform for the project.

  • Launch timing

    Ready when the moment is. Venture Shape can accommodate accelerated schedules and coordinate launches around key events.

Execution surface

Investor Presentation Systems

Investor narratives built across live presentations, distribution materials, partnering formats and supporting scientific figures.

One communication hierarchy, carried into every variant of the deck rather than rebuilt for each audience.

  • Slide 1
  • Slide 2
  • Slide 3
  • Slide 4
  • Slide 5
  • Slide 6
  • Slide 7
  • Slide 8
  • Slide 9
  1. Scientific Visual Experiences

    Static and interactive scientific visuals that make complex mechanisms, platforms, programs and pipelines easier to understand across investor-facing materials.

Start here

Not sure which surface comes first?

Start with the communication problem.

Start a Conversation
What you bring
  1. Deck
  2. Website
  3. Science
  4. Pipeline
What we resolve
  • What leads
  • What supports
  • What gets cut
  • How it's shown